Nag SA - Search Results

1

KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology.

Wang W, Ao L, Rayburn ER, Xu H, Zhang X, Zhang X, Nag SA, Wu X, Wang MH, Wang H, Van Meir EG, Zhang R. Wang W, et al. Among authors: nag sa. PLoS One. 2012;7(9):e44883. doi: 10.1371/journal.pone.0044883. Epub 2012 Sep 13. PLoS One. 2012. PMID: 23028659 Free PMC article.

2

Pharmacokinetics and Pharmacodynamics in Breast Cancer Animal Models.

Wang W, Nag S, Zhang R. Wang W, et al. Methods Mol Biol. 2016;1406:271-87. doi: 10.1007/978-1-4939-3444-7_23. Methods Mol Biol. 2016. PMID: 26820963 Free PMC article.

3

Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2.

Wang W, Zhang X, Qin JJ, Voruganti S, Nag SA, Wang MH, Wang H, Zhang R. Wang W, et al. Among authors: nag sa. PLoS One. 2012;7(7):e41586. doi: 10.1371/journal.pone.0041586. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22911819 Free PMC article.

4

NFAT as cancer target: mission possible?

Qin JJ, Nag S, Wang W, Zhou J, Zhang WD, Wang H, Zhang R. Qin JJ, et al. Biochim Biophys Acta. 2014 Dec;1846(2):297-311. doi: 10.1016/j.bbcan.2014.07.009. Epub 2014 Jul 26. Biochim Biophys Acta. 2014. PMID: 25072963 Free PMC article. Review.

5

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Wang W, Nag S, Zhang X, Wang MH, Wang H, Zhou J, Zhang R. Wang W, et al. Med Res Rev. 2015 Mar;35(2):225-85. doi: 10.1002/med.21327. Epub 2014 Aug 28. Med Res Rev. 2015. PMID: 25164622 Free PMC article. Review.

6

A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study.

Nag S, Qin JJ, Patil S, Deokar H, Buolamwini JK, Wang W, Zhang R. Nag S, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15;969:235-240. doi: 10.1016/j.jchromb.2014.08.030. Epub 2014 Aug 28. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 25195025 Free PMC article.

7

The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models.

Wang W, Qin JJ, Voruganti S, Srivenugopal KS, Nag S, Patil S, Sharma H, Wang MH, Wang H, Buolamwini JK, Zhang R. Wang W, et al. Nat Commun. 2014 Oct 1;5:5086. doi: 10.1038/ncomms6086. Nat Commun. 2014. PMID: 25271708 Free PMC article.

8

Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice.

Nag S, Qin JJ, Voruganti S, Wang MH, Sharma H, Patil S, Buolamwini JK, Wang W, Zhang R. Nag S, et al. Biomed Chromatogr. 2015 May;29(5):654-63. doi: 10.1002/bmc.3327. Epub 2014 Oct 8. Biomed Chromatogr. 2015. PMID: 25294254 Free PMC article.

9

RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo.

Wang W, Cheng J, Qin JJ, Voruganti S, Nag S, Fan J, Gao Q, Zhang R. Wang W, et al. Oncotarget. 2014 Nov 30;5(22):11604-19. doi: 10.18632/oncotarget.2598. Oncotarget. 2014. PMID: 25344099 Free PMC article.

10

Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.

Voruganti S, Qin JJ, Sarkar S, Nag S, Walbi IA, Wang S, Zhao Y, Wang W, Zhang R. Voruganti S, et al. Oncotarget. 2015 Aug 28;6(25):21379-94. doi: 10.18632/oncotarget.4091. Oncotarget. 2015. PMID: 26041888 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters